logo

ACRV’s Stock Market Pendulum: Swinging Between Gains and Losses

CROX

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -74.25%.However, over the last six months, we can see a stronger performance of -80.77%. Over the last 30 days, the price of ACRV has leaped by -38.49%. And in the last five days, it has fallen by -18.85%.

Acrivon Therapeutics Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $10.29 on 05/03/24 and a low of $1.30 for the same time frame on 04/09/25.

52-week price history of ACRV Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Acrivon Therapeutics Inc’s current trading price is -84.94% away from its 52-week high, while its distance from the 52-week low is 19.23%. The stock’s price range during this period has varied between$1.30 and $10.29. The Acrivon Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.81 million for the day, a figure considerably higher than their average daily volume of 0.44 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Acrivon Therapeutics Inc (ACRV) has experienced a quarterly decline of -72.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 48.60M and boasts a workforce of 78 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.9548, with a change in price of -6.0300. Similarly, Acrivon Therapeutics Inc recorded 301,218 in trading volume during the last 100 days, posting a change of -79.55%.

ACRV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ACRV stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.

ACRV Stock Stochastic Average

As of today, Acrivon Therapeutics Inc’s raw stochastic average for the last 50 days stands at 5.23%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 25.00%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 31.40% and 29.61%, respectively.

Most Popular